Skip to main content
. 2011 Oct 14;16(6):213–220. doi: 10.1016/j.rpor.2011.08.003

Table 3.

Major eligibility criteria for APBI in clinical setting.

Society (Ref.) Age Tumour size Histology DCIS Margin status Induction therapy Nodal status Tumour grade EIC
ASTRO44,45 ≥60 years ≤2 cm Unifocal, unicentric invasive ductal carcinoma or other favourable types Not allowed Tumour-free within 2 mm Not allowed N0 Any Not allowed
GEC-ESTRO46 ≥50 years <3 cm Unifocal, unicentric invasive ductal carcinoma or other favourable types Not allowed Tumour-free within 2 mm Not allowed N0 Any Not allowed
ABS47 >50 years ≤3 cm Invasive ductal carcinoma Not allowed Negative Not specified N0 Not specified Not specified
ASBS47 >45 years ≤3 cm Invasive ductal carcinoma and/or DCIS Allowed Negative Not specified SN negative Not specified Not specified

Abbreviations: ABS, American Brachytherapy Society; ASBS, American Society of Breast Surgeons; ASTRO, The American Society for Radiation Oncology; DCIS, ductal carcinoma in situ; EIC, extensive intraductal component; GEC-ESTRO, Groupe Europeen de Curietherapie-European Society for Therapeutic Radiology and Oncology; SN, sentinel node.